Pharmaceutical

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in on-going clinical studyMarlborough,…

7 months ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

First Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management GuidanceRehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences…

7 months ago

CIT Srl Charts a Visionary Path in Supply Chain Digitalization with TraceLink’s Multienterprise Information Network Tower (MINT)

BOSTON, May 15, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced…

7 months ago

Spectrum Science Expands Integrated Strategic Platform With Launch of Full-Service Media Offering

Led by industry veteran Chad Childress, Spectrum Science Media delivers omnichannel performance media with a built-in research and insights team…

7 months ago

Axtria and Genloop Deliver Domain-Trained LLMs: Advancing Agentic AI in Life Sciences with Enhanced Accuracy, Flexibility, and Cost Efficiency

BERKELEY HEIGHTS, N.J., May 15, 2025 /PRNewswire/ -- Axtria Inc., a global leader in AI-powered data analytics solutions for the…

7 months ago

datma Recognized for Enabling Privacy-First Data Collaboration in 2025 MedTech Breakthrough Awards

Company recognized as Best Compliance Management Solution Provider for its secure, federated approach to healthcare data collaboration. BEAVERTON, Ore., May…

7 months ago

Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial

Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is…

7 months ago

New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline

NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and…

7 months ago

Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting

Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled for Thursday,…

7 months ago